CAREER: Adaptive and regulatory diversity in natural CRISPR-Cas systems
职业:天然 CRISPR-Cas 系统中的适应性和调控多样性
基本信息
- 批准号:2235762
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
CRISPR-Cas systems are anti-viral immune systems widespread in microbial genomes. Bacteria are “immunized” during viral infection when a fragment of invader DNA (called a spacer) is captured and used as a sequence-specific immunological memory to recognize and destroy matching sequences. This project will investigate the mechanisms by which diverse CRISPR systems acquire immunological memory, and to discover factors that bacteria use to control this process. The programmable sequence-specific nucleic acid recognition and biochemical activities of CRISPR-Cas nucleases have been exploited for a wide range of biotechnologies. Understanding how these systems are programmed by their natural hosts will better enable researchers to generate diverse CRISPR libraries in vivo, and will benefit CRISPR-based technologies aimed at molecular recording of cellular histories. This education plan of this project is comprised of a course-based research experience in which undergraduate participants will systematically measure interference by diverse CRISPR types targeting different viruses. This course will give students hands-on experience with the concepts of molecular biology and viral infection, and also represents a defined framework for students to rapidly generate and publish novel data.The goal of this research is to understand how diverse CRISPR types acquire new spacers from foreign genetic elements. Listeria seeligeri and its phages is a tractable model for studying four distinct CRISPR types, including the RNA-targeting CRISPR-Cas13 system. This model bacterium has been extremely useful for investigating the mechanisms and consequences of Cas13-mediated interference during type VI CRISPR immunity. However, the processes underlying the initial spacer acquisition events that establish immunity remain unclear. This proposal will employ next generation sequencing to detect rare acquisition events with high sensitivity. CRISPR-associated genes will be systematically mutagenized to assess their contributions to immunization. The CRISPR-Cas13 system uniquely targets RNA rather than DNA, and the acquired spacers will be examined to understand whether and how this system specifies the capture of transcribed target sequences. Finally, spacer acquisition will be biochemically reconstituted to investigate the mechanistic basis of spacer integration site selection.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
CRISPR-Cas系统是广泛存在于微生物基因组中的抗病毒免疫系统。在病毒感染期间,当入侵者DNA的片段(称为间隔区)被捕获并用作序列特异性免疫记忆以识别和破坏匹配序列时,细菌被“免疫”。该项目将研究不同CRISPR系统获得免疫记忆的机制,并发现细菌用于控制这一过程的因素。CRISPR-Cas核酸酶的可编程序列特异性核酸识别和生物化学活性已被用于广泛的生物技术。了解这些系统是如何被它们的天然宿主编程的,将使研究人员能够更好地在体内生成多样化的CRISPR文库,并将有利于基于CRISPR的技术,旨在分子记录细胞历史。该项目的教育计划包括一个基于课程的研究经验,其中本科生参与者将系统地测量针对不同病毒的不同CRISPR类型的干扰。本课程将为学生提供分子生物学和病毒感染概念的实践经验,并为学生提供快速生成和发布新数据的定义框架。本研究的目标是了解不同的CRISPR类型如何从外源遗传元件中获得新的间隔区。李斯特菌及其宿主是研究四种不同CRISPR类型的易处理模型,包括RNA靶向CRISPR-Cas 13系统。这种模式细菌对于研究VI型CRISPR免疫过程中Cas 13介导的干扰的机制和后果非常有用。然而,建立免疫力的初始间隔区获取事件的潜在过程仍不清楚。该提案将采用下一代测序以高灵敏度检测罕见的采集事件。将对CRISPR相关基因进行系统性诱变,以评估其对免疫的贡献。CRISPR-Cas 13系统独特地靶向RNA而不是DNA,并且将检查获得的间隔区以了解该系统是否以及如何指定转录的靶序列的捕获。最后,将对间隔物的获取进行生化重组,以调查间隔物整合地点选择的机械基础。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Meeske其他文献
Alexander Meeske的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Kynurenine-dependent redox signaling at the interface between innate and adaptive immunity
先天免疫和适应性免疫之间界面的犬尿氨酸依赖性氧化还原信号传导
- 批准号:
10749210 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Innate and Adaptive Immune Markers in Farming Lifestyle and Early Atopic Diseases
农业生活方式和早期特应性疾病中的先天性和适应性免疫标志物
- 批准号:
10633369 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
NSF Postdoctoral Fellowship in Biology FY 2021: Untangling the roles of genetic and regulatory mechanisms in adaptive evolutionary responses to climate change
2021 财年 NSF 生物学博士后奖学金:阐明遗传和调控机制在气候变化适应性进化反应中的作用
- 批准号:
2109544 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Fellowship Award
DYNAMICS OF M. TUBERCULOSIS-SPECIFIC INNATE AND ADAPTIVE IMMUNITY DURING PREGNANCY AND POSTPARTUM IN WOMEN WITH HIV
HIV 感染女性妊娠期和产后结核分枝杆菌特异性先天性和适应性免疫的动态
- 批准号:
10356601 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
DYNAMICS OF M. TUBERCULOSIS-SPECIFIC INNATE AND ADAPTIVE IMMUNITY DURING PREGNANCY AND POSTPARTUM IN WOMEN WITH HIV
HIV 感染女性妊娠期和产后结核分枝杆菌特异性先天性和适应性免疫的动态
- 批准号:
10674692 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Plasticity and Nitric Oxide Signaling: Identifying the Novel Adaptive Mechanisms Associated with Response to Hypoxia
可塑性和一氧化氮信号传导:识别与缺氧反应相关的新型适应性机制
- 批准号:
10540738 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Plasticity and Nitric Oxide Signaling: Identifying the Novel Adaptive Mechanisms Associated with Response to Hypoxia
可塑性和一氧化氮信号传导:识别与缺氧反应相关的新型适应性机制
- 批准号:
10351389 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Adaptive evolution to acid soil reveals gene regulatory networks for aluminum tolerance
对酸性土壤的适应性进化揭示了铝耐受性的基因调控网络
- 批准号:
22H02227 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
阿尔茨海默病中先天免疫人类小胶质细胞和适应性免疫 Tregs 之间的串扰
- 批准号:
10686979 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别: